Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00128388 · ClinicalTrials.gov registry record · Phase 2

Psychodynamic Therapy for Treating Panic Disorder

A Phase 2 study, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
Phase 2
Development phase
49
Enrollment target

NCT00128388: Completed Phase 2 study, sponsored by Weill Medical College of Cornell University.

NCT00128388 is a Phase 2 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 49 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (63% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00128388, a Phase 2 study, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
Phase 2
Development phase
49 participants
Enrollment target

Study Summary

This study will determine the effectiveness of a manualized form of brief psychodynamic psychotherapy in comparison with applied relaxation training in treating adults with panic disorder.

Interventions

  • OTHER ART
  • OTHER PFPP

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2000-02
Est. Completion 2005-07
Phase Phase 2

What the finished NCT00128388 record still lists

NCT00128388 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (63% lower).

The record links to 0 conditions, and to 2 interventions - of which ART is the first listed.

NCT00128388 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00128388 about?

NCT00128388 is a clinical study titled "Psychodynamic Therapy for Treating Panic Disorder". This study will determine the effectiveness of a manualized form of brief psychodynamic psychotherapy in comparison with applied relaxation training in treating adults with panic disorder.

What is the current status of trial NCT00128388?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 49 participants. The study started on 2000-02. Estimated completion is 2005-07.

What interventions are being tested in trial NCT00128388?

The interventions under investigation include: ART (OTHER), PFPP (OTHER).

Who is sponsoring clinical trial NCT00128388?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00128388's enrollment target sits among peer trials

49 1261st of 2000 higher than 736 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02704858 · 49 participants · Phase 1

    Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

  • NCT03516708 · 49 participants · Phase 1

    Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer

  • NCT03692429 · 49 participants · Phase 1

    alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

  • NCT04329494 · 49 participants · Phase 1

    PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00128388, the US trial registry maintained by the National Library of Medicine. NCT00128388 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.